Haemonetics Retained Earnings (Accumulated Deficit) 2010-2024 | HAE
Haemonetics retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Haemonetics Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $360 |
| 2023 | $253 |
| 2022 | $202 |
| 2021 | $158 |
| 2020 | $79 |
| 2019 | $161 |
| 2018 | $267 |
| 2017 | $290 |
| 2016 | $316 |
| 2015 | $420 |
| 2014 | $433 |
| 2013 | $398 |
| 2012 | $401 |
| 2011 | $374 |
| 2010 | $335 |
| 2009 | $310 |
| Haemonetics Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $392 |
| 2024-09-30 | $369 |
| 2024-06-30 | $387 |
| 2024-03-31 | $360 |
| 2023-12-31 | $340 |
| 2023-09-30 | $309 |
| 2023-06-30 | $284 |
| 2023-03-31 | $253 |
| 2022-12-31 | $224 |
| 2022-09-30 | $204 |
| 2022-06-30 | $222 |
| 2022-03-31 | $202 |
| 2021-12-31 | $193 |
| 2021-09-30 | $169 |
| 2021-06-30 | $155 |
| 2021-03-31 | $158 |
| 2020-12-31 | $169 |
| 2020-09-30 | $137 |
| 2020-06-30 | $89 |
| 2020-03-31 | $79 |
| 2019-12-31 | $70 |
| 2019-09-30 | $86 |
| 2019-06-30 | $99 |
| 2019-03-31 | $161 |
| 2018-12-31 | $141 |
| 2018-09-30 | $194 |
| 2018-06-30 | $190 |
| 2018-03-31 | $267 |
| 2017-12-31 | $324 |
| 2017-09-30 | $330 |
| 2017-06-30 | $310 |
| 2017-03-31 | $290 |
| 2016-12-31 | $341 |
| 2016-09-30 | $326 |
| 2016-06-30 | $306 |
| 2016-03-31 | $316 |
| 2015-12-31 | $325 |
| 2015-09-30 | $384 |
| 2015-06-30 | $387 |
| 2015-03-31 | $420 |
| 2014-12-31 | $424 |
| 2014-09-30 | $411 |
| 2014-06-30 | $409 |
| 2014-03-31 | $433 |
| 2013-12-31 | $423 |
| 2013-09-30 | $407 |
| 2013-06-30 | $390 |
| 2013-03-31 | $398 |
| 2012-12-31 | $410 |
| 2012-09-30 | $413 |
| 2012-06-30 | $411 |
| 2012-03-31 | $401 |
| 2011-12-31 | $383 |
| 2011-09-30 | $365 |
| 2011-06-30 | $391 |
| 2011-03-31 | $374 |
| 2010-12-31 | $353 |
| 2010-09-30 | $333 |
| 2010-06-30 | $312 |
| 2010-03-31 | $335 |
| 2009-12-31 | $331 |
| 2009-09-30 | $339 |
| 2009-06-30 | $328 |
| 2009-03-31 | $310 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.485B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.007B | 27.90 |
| Boston Scientific (BSX) | United States | $155.135B | 38.84 |
| Stryker (SYK) | United States | $149.698B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $129.877B | 0.00 |
| Medtronic (MDT) | Ireland | $110.440B | 16.12 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.984B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.101B | 27.36 |
| ResMed (RMD) | United States | $36.449B | 27.38 |
| GE HealthCare Technologies (GEHC) | United States | $33.384B | 15.85 |
| Agilent Technologies (A) | United States | $32.046B | 21.17 |
| Terumo (TRUMY) | Japan | $27.153B | 35.27 |
| Koninklijke Philips (PHG) | Netherlands | $22.822B | 16.41 |
| Insulet (PODD) | United States | $22.662B | 88.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.138B | 12.29 |
| Baxter (BAX) | United States | $15.929B | 11.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.591B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.618B | 23.03 |
| Lantheus Holdings (LNTH) | United States | $5.520B | 13.92 |
| Prestige Consumer Healthcare (PBH) | United States | $4.305B | 19.23 |
| Perrigo (PRGO) | Ireland | $3.614B | 9.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.459B | 25.51 |
| Envista Holdings (NVST) | United States | $3.066B | 25.48 |
| QuidelOrtho (QDEL) | United States | $2.234B | 15.36 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.07 |
| AtriCure (ATRC) | United States | $1.599B | 0.00 |
| Neogen (NEOG) | United States | $1.424B | 18.22 |
| AdaptHealth (AHCO) | United States | $1.220B | 12.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.209B | 27.19 |
| BioLife Solutions (BLFS) | United States | $1.045B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 9.37 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 12.35 |
| Evolus (EOLS) | United States | $0.645B | 0.00 |
| CeriBell (CBLL) | United States | $0.636B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.586B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.516B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.499B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.443B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.401B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.95 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 49.60 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| ZimVie (ZIMV) | United States | $0.242B | 11.00 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Brainsway (BWAY) | Israel | $0.188B | 49.90 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.51 |
| Quanterix (QTRX) | United States | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Jin Medical (ZJYL) | China | $0.129B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.83 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.57 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |